Skadden advised MorphoSys AG on the €115 million international private placement of more than 2.6 million new shares via an accelerated book-building transaction as well as the admission of the new shares to trading on the Frankfurt Stock Exchange.
Skadden advised MorphoSys AG on the €115 million international private placement of more than 2.6 million new shares via an accelerated book-building transaction as well as the admission of the new shares to trading on the Frankfurt Stock Exchange.